PolyPid Ltd.

Home » PolyPid Ltd.

IPO

PolyPid Ltd.

They are a clinical-stage pharmaceutical company focused on developing and commercializing novel, locally administered therapies using our transformational PLEX (Polymer-Lipid Encapsulation matriX) technology.

Symbol

PLPD

Price Range
$21.00 - $24.00

Final Shares
3,333,333

Anticipated Date
TBD

Underwriters
Goldman Sachs, Cowen

To view the prospectus for PolyPid Ltd. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253